A new exploratory analysis of the HIMALAYA phase III trial involving patients with unresectable hepatocellular carcinoma ...

肝癌是全球范围内常见的恶性肿瘤，而世界上近一半的肝癌病例集中在中国，且大部分与乙型肝炎病毒感染相关[1]。在肝癌的分型中，临床上常依据肿瘤大小将肝癌分为：微小肝癌（直径 ＜ 1 cm）、小肝癌（直径 1-3 cm）、中肝癌（直径 3-5 ...

肝细胞癌（HCC）约占肝癌病例的 80% 至 ...

Domestic researchers have found for the first time in the world that immuno-cancer drugs atetzolizumab plus bevacizumab ...

中央医院解剖病理学部兼新科研分子与细胞生物学研究院首席科学家杨宝诚博士说，本地有高达70%的肝癌患者五年内病症会复发。“TIMES在预测这些结果方面取得了重大进展，使临床医生能够尽可能提前介入。这将显著提升患者护理质量和存活率。” ...

近期研究已证实放疗在肝细胞癌（HCC）治疗中的重要作用。此前的研究表明，放疗可促进免疫细胞向肿瘤微环境浸润，从而可能增强免疫治疗的效果。基于此，研究人员研究了莲心碱、放疗和免疫治疗联合治疗方案的协同作用。

导语据世界卫生组织（World Health Organization，WHO）报道，2019年全球约有3. 16亿慢性乙型肝炎（chronic hepatitis B，CHB）感染者，82万人死于乙型肝炎病毒（hepatitis B ...

AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths ...

Developed by scientists from the Institute of Molecular and Cell Biology (IMCB) under the agency in collaboration with the ...

Singapore scientists have unveiled an AI tool that predicts liver cancer relapse with 82% accuracy, turning pathology slides ...

There were 74 hepatocellular carcinomas. The sizes of the resected hepatocellular carcinomas ranged from 1.3 cm to 24.0 cm, with a mean of 8.1 cm. Fifty-four (73%) of the tumors were solitary.

Among all resected hepatocellular carcinomas in non-cirrhotic livers over this time period, the prevalence of 16% with HCV infection was significantly greater than that expected by chance.